News

Pegasystems Insider Transaction: Stock Options Worth $2.80M

Pegasystems Insider Transaction: Stock Options Worth $2.80M

Recent Insider Transactions at Pegasystems

There has been notable activity concerning Pegasystems (NASDAQ: PEGA) recently. The Chief Product Officer, Rifat Kerim Akgonul, exercised a significant amount of company stock options, culminating in a sum of $2.80 million. This transaction was publicly disclosed in an SEC filing.

A Strategic Move

Details of the Transaction

Akgonul executed the exercise of options allowing him to purchase 70,000 shares of Pegasystems. This move outlines a strategic decision amid fluctuating market dynamics, and the total transaction was recorded at $2,801,500.

Current Market Context

Presently, Pegasystems shares have faced a slight decrease, with a drop of 0.52% as they opened at a price of $65.15. Rifat's exercised shares equate to approximately $2,801,500, pointing to the substantial investment at stake.

Understanding Pegasystems: Who They Are

A Brief Introduction

Founded in 1983, Pegasystems is a leader in software solutions focusing on customer engagement and business process management. Their flagship offering, the Pega Infinity platform, integrates business process management with customer relationship management, primarily serving large enterprises in sectors like finance, insurance, and healthcare.

Financial Overview

Pegasus’s recent financial performances show resilience, with a significant revenue growth of approximately 17.32% as of September. However, in comparison to industry peers within the Information Technology sector, this growth rate is notably below average.

Financial Performance Insights

Analyzing Financial Metrics

Gross Margin: Pegasystems boasts a robust gross margin of 72.23%, indicating strong cost management and profitability relative to industry competitors.

  • Earnings per Share (EPS): Currently, the EPS is registered at 0.25, reflecting a decline compared to industry averages.
  • Debt Management: The company maintains a conservative debt-to-equity ratio of 0.13, positioning it favorably in terms of financial stability.

Valuation Metrics: A Closer Look

  • Price to Earnings (P/E) Ratio: At 42.66, the P/E ratio is lower than average in the industry, indicating potential undervaluation of the stock.
  • Price to Sales (P/S) Ratio: The P/S ratio stands at 7.2, which may present a buying opportunity for value-oriented investors.
  • Enterprise Value to EBITDA (EV/EBITDA): The current EV/EBITDA ratio is 30.15, suggesting that the stock may be undervalued, appealing to value-seeking investors.

Market Capitalization and Positioning

Pegasystems' market capitalization falls below typical industry benchmarks, which could be attributed to several factors like future growth expectations and operational capabilities.

Why Monitor Insider Transactions?

While insider trading isn’t the sole determinant for investment strategies, it does provide valuable insights into the confidence levels of company leadership regarding stock performance.

The Importance of Transparency

According to regulations, insiders must report transactions through a Form 4 within two business days. This includes any officer or significant stakeholder holding a major equity share in the company.

Frequently Asked Questions

What recent insider transactions occurred at Pegasystems?

The Chief Product Officer at Pegasystems exercised options to purchase 70,000 shares valued at approximately $2.80 million.

What is the current status of Pegasystems’ stock price?

Pegasus shares are currently priced at $65.15, reflecting a 0.52% decrease.

How does Pegasystems compare to its competitors?

Pegasystems shows revenue growth, although it's below the average growth rate seen among its industry peers within the Information Technology sector.

What does Pegasystems focus on in its offerings?

The company primarily focuses on software solutions for customer engagement and business process management, particularly for large enterprises.

Why are insider transactions important for investors?

Insider transactions can signal management’s expectations for the company’s future performance, though they should not be the sole factor in making investment decisions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Amy Wilson Joins ITSA Board: A New Era for UBI?

Updated Category News Views 6

An Unexpected Turn in the UBI Movement In a world where tech and economic security must dance together, minding the steps is crucial. And this time, Amy Wilson's got her dancing shoes on. On September 24, 2026, the Income To Support All (ITSA) Foundation made some waves by adding Wilson to its board of directors, a move showing they're more serious than ever about...

Continue Reading
Quantum Sky's Strategic Leadership Overhaul Targets Growth

Updated Category News Views 5

Executive Shake-Up Aims for Stronger Federal Market Alignment Buckle up, folks—there's some major chess-piecing happening at Quantum Sky. They've just named not one or two, but three executive bigwigs to head up their core business groups. This isn’t just some ceremonial reshuffle. Nah, it’s bigger. They're redefining how they tackle the Department of War, Intel &...

Continue Reading
NSF Backs New Space Projects: Cooling & Drug Delivery

Updated Category News Views 4

You know, every time we think we're at the edge of current science, space reminds us how little we actually know. From the International Space Station up there in low Earth orbit, fresh experiments are kicking off to change what we understand about electronics cooling and drug delivery. It's a classic scenario of reaching for the stars to help us out back here on Earth....

Continue Reading
Subaru, Motorq Offer Hardware-Free Fleet Telematics Insights

Updated Category News Views 4

An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...

Continue Reading
Wrensilva Unveils Studio Console in White Oak

Updated Category News Views 4

The White Oak Revolution Out of San Diego, Wrensilva's giving audiophiles a new reason to tune in: the Studio record console now comes dressed to impress in White Oak. This marks a fresh chapter in their craftsmanship tale, marrying sleek design with the earthy charm of this beloved hardwood. And guess what? The demand for serene home listening setups is peaking like...

Continue Reading
New Podcast by Paralyzed Veterans of America Offers Unique Insights

Updated Category News Views 5

Empowering Veterans Through Storytelling Some stories don't just rattle around in your headphones—they stick with you. The 'Voices of PVA' podcast, launched by Paralyzed Veterans of America, aims to do exactly that. It's not just a podcast; it's a platform where voices of veterans and people with spinal cord injuries like MS and ALS aren't just heard, they're amplified....

Continue Reading
Clarius Named in TIME's Top HealthTech 2026 Again

Updated Category News Views 6

When a company gets the nod from TIME two years in a row, you know they’re not just tinkering with gadgets—they’re changing the game. Clarius Mobile Health, with its cutting-edge wireless ultrasound tech, has cemented its place in TIME's World's Top HealthTech Companies of 2026. Last I checked, repeating this kind of recognition never comes easy in such a fiercely...

Continue Reading
United Apartment Group's Leadership Revamp Signals Growth

Updated Category News Views 7

A Bold Leadership Expansion Big moves are afoot at United Apartment Group (UAG). They're not just refilling some roles here; they're rebooting their lineup with serious hitters—Woody Stone and Lenzie O’Connor are now steering the ship on business development and client services, eager to drive the company to new heights. Woody Stone: Fueled by Experience Stone isn't...

Continue Reading
VERTESS Tops Axial's 2026 Healthcare M&A Advisor List

Updated Category News Views 5

Strength Takes Top Spot in Healthcare M&A VERTESS has grabbed the gold medal in healthcare sell-side M&A, something that didn't just fall from the sky. Axial gave them the nod as the cream of the crop among the Top 50 Lower Middle Market Healthcare M&A Advisors for 2026. Evaluating the Strengths that Set VERTESS Apart When Axial, that private deal network that's all about...

Continue Reading
Stravito's MCP Server Revolutionizes AI in Business

Updated Category News Views 6

We're seeing another big swing in how enterprises weave AI into the fabric of decision-making. Stravito, an enterprise customer intelligence platform, launched its Model Context Protocol (MCP) Server. This thing brings company-owned research right into the gizmos teams already use. Now, businesses aren't left groping in the dark figuring out their next moves—pretty...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Breakthrough in Mesothelioma Treatment from Cyncado

Updated Category News Views 142

Exciting Developments in Cancer Treatment AlphaTON Capital Corp, a leader in innovative therapies, and its oncology-focused subsidiary, Cyncado Therapeutics, are making impressive strides in the fight against cancer. Recent findings have unveiled that selective A2B receptor inhibition can significantly reduce PD-L1 tumor expression while also directly suppressing the...

Continue Reading
Key Financial Highlights and Upcoming Events for Vaisala

Updated Category News Views 79

Vaisala's 2025 Financial Reporting Schedule Vaisala Corporation has laid out an ambitious plan for its financial disclosures throughout 2025. The company is committed to transparency, as seen in its schedule for the Financial Statement Release and Interim Reports. Here’s a detailed breakdown of the financial reporting timeline for Vaisala: Key Dates for Financial...

Continue Reading
MPE Partners Invests in SKB Cases to Enhance Growth Potential

Updated Category News Views 368

MPE Partners Makes Strategic Investment in SKB Cases MPE Partners, also known as Morgenthaler Private Equity, has announced an exciting investment in SKB Cases, a prominent manufacturer known for its specialty protective cases. With a robust customer base exceeding 2,000 clients across military, industrial, music, and pro AV sectors, this strategic move is set to...

Continue Reading
Allergy/Immunology Field Eyes Workforce Expansion, Equity

Updated Category News Views 6

Expanding the Allergist Workforce You don’t get too far trading stocks without noticing how supply and demand rule the world, and right now, the allergist workforce feels like it's on the supply side of a losing battle. Folks behind the National Medical Association Allergy, Asthma, and Immunology Section, along with their pals at the American Academy of Allergy, Asthma...

Continue Reading
Introducing LEUKOMAX XL: Transforming Cell and Gene Therapy

Updated Category News Views 59

BioIVT Launches LEUKOMAX XL for Enhanced Cellular Research BioIVT, a leading provider of biospecimen solutions, has launched a groundbreaking product called LEUKOMAX XL. This innovative leukopak solution offers researchers an exceptional advantage by providing a minimum of 15 billion total nucleated cells (TNC) from a single donor collection. With a significant...

Continue Reading